This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Machine learning can help improve echocardiography interpretation of heart tumors, according to research published on July 1 in Informatics in Medicine Unlocked. A team led by Seyed-Ali Sadegh-Zadeh, PhD, from Staffordshire University in England found that its machine-learning model achieved high performance in diagnosing heart tumors, including a near-perfect area under the curve (AUC) score.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
A paper in the J ournal of Vascular and Interventional Radiology offers new guidance on how ablation volumes affect renal function in solitary kidneys and highlights ranges that pose the least risk to patients.
FDG-PET/CT imaging can reduce unnecessary surgeries to remove residual neck cancer in patients who have undergone chemoradiotherapy, according to a study published June 28 in Radiotherapy and Oncology. In an analysis of treated patients with head and neck squamous cell carcinoma (HNSCC), integrating FDG-PET/CT helped select patients for surgery and ruled it out in a significant number of others, noted lead author Arash Navran, MD, of the Netherlands Cancer Institute in Amsterdam.
FDG-PET/CT imaging can reduce unnecessary surgeries to remove residual neck cancer in patients who have undergone chemoradiotherapy, according to a study published June 28 in Radiotherapy and Oncology. In an analysis of treated patients with head and neck squamous cell carcinoma (HNSCC), integrating FDG-PET/CT helped select patients for surgery and ruled it out in a significant number of others, noted lead author Arash Navran, MD, of the Netherlands Cancer Institute in Amsterdam.
Individuals who use e-cigarettes are less likely to undergo lung cancer screening (LCS), researchers have reported. A team led by Qian Wang, MD, of University Hospitals Seidman Cancer Center in Cleveland, found that, after adjusting for comorbidities (coronary heart disease or myocardial infarction, stroke, asthma, chronic obstructive pulmonary disease, chronic kidney disease, diabetes, and arthritis), this population has 21% lower odds of participating in low-dose CT (LDCT) LCS compared to tho
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The U.S. Food and Drug Administration (FDA) has approved Eli Lilly's drug donanemab (Kisunla) for the treatment of early Alzheimer's disease, including mild cognitive impairment or mild dementia. Donanemab is a monoclonal antibody that targets and clears beta-amyloid protein in the brain. It is the second drug approved by the FDA that directly targets amyloid plaque, which is believed to drive cognitive impairment.
The board of directors at AI imaging firm Body Vision Medical has named Matt Baker as the company's chief executive officer (CEO). He replaces David Webster, who has stepped down from the role. Baker most recently served as the company's chief operating officer (COO). He has more than 30 years of experience in the global medical device and healthcare IT industries.
A colder nose and warmer cheeks may be a telltale sign of rising blood pressure. Researchers discovered that temperatures in different face regions are associated with various chronic illnesses, such as diabetes and high blood pressure. These temperature differences are not easily perceptible by one's own touch but can instead be identified using specific AI-derived spatial temperature patterns that require a thermal camera and a data-trained model.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
Large language models can generate summaries that could help patients better understand their radiology reports, though human oversight is needed, according to research published July 1 in the Journal of the American College of Radiology. A team led by Kayla Berigan, MD, from the University of Vermont Medical Center in Burlington, found that patients who received radiology reports, with and without a large language model-generated summary, were more likely to have a better understanding of their
The American Medical Association (AMA) has issued a Category III Current Procedural Terminology (CPT) code for Ultromics' EchoGo Heart Failure. The technology uses AI to detect heart failure with preserved ejection fraction from a single, routinely acquired echocardiographic video. It incorporates large datasets and AI algorithms to identify patterns and correlations that may go undetected by traditional diagnostic methods, Ultromics said.
mtaschetta-millane Tue, 07/02/2024 - 09:50 July 2, 2024 — Delphinus Medical Technologies , a pioneering medical imaging company that developed the SoftVue Breast Ultrasound Tomography (UST), announced today the publication of a study comparing mammography in conjunction with SoftVue UST vs mammography alone in women with dense breasts. The study concluded that in women with dense breasts, mammography plus SoftVue UST improved cancer detection by radiologists versus mammography alone.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Serac Healthcare has received fast-track designation from the U.S. Food and Drug Administration (FDA) for its diagnostic SPECT-CT agent maraciclatide technetium-99m to diagnose superficial peritoneal endometriosis (SPE) in women ages 16 years and older. SPE is the earliest and most common form of endometriosis, comprising approximately 80% of all cases.
Here is a look at what viewers were reading during the month of June on itnonline: 1. GE HealthCare Introduces Groundbreaking Developments in Precision Care at SNMMI24 2.
AI developer Spectral AI has achieved 100% pediatric patient enrollment at burn centers for its 2024 study designed to validate the AI-driven algorithm used by the company's DeepView System for its burn indication. The study is scheduled to be completed in the fourth quarter of 2024 and is the final clinical trial before the company seeks approval from the U.S.
A new imaging technology has been shown to enhance the detection of metastatic small cell lung cancer and neuroendocrine prostate cancer, which conventional imaging methods might miss.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
Emphasizing core concepts of sound ergonomics, accessibility, inclusivity, personalization, and convenient storage can help foster reading room environments with minimal distraction and optimal productivity.
A University of Alberta study shows that PET/CT imaging using a new tracing agent is more accurate at determining the extent of prostate cancer than the current standard MRI for intermediate and high-risk cases.
The EchoGo Heart Failure platform is reportedly the only AI-powered technology to receive a CPT reimbursement code for echocardiography detection of heart failure with preserved ejection fraction.
A patient enters the ED with severe lower abdominal pain and the ED physician knows just what to do. The patient is evaluated and sent for a CT scan. Just as suspected, the CT comes back positive for acute diverticulitis with a perforation. The patient is treated with drainage and IV antibiotics and the issue is resolved. But is it possible that this health system missed a care opportunity from this CT scan?
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content